Contract with Customer, Liability, Current in USD of Spyre Therapeutics, Inc. from Q4 2020 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.
Summary
Spyre Therapeutics, Inc. quarterly Contract with Customer, Liability, Current history and change rate from Q4 2020 to Q4 2023.
  • Spyre Therapeutics, Inc. Contract with Customer, Liability, Current for the quarter ending 31 Dec 2023 was $0.000, a 100% decline year-over-year.
Contract with Customer, Liability, Current, Quarterly (USD)
Contract with Customer, Liability, Current, YoY Quarterly Change (%)

Spyre Therapeutics, Inc. Quarterly Contract with Customer, Liability, Current (USD)

Period Value YoY Chg Change % Date Report Filed
Q4 2023 $0 -$517K -100% 31 Dec 2023 10-K/A 18 Nov 2024
Q3 2023 $0 -$2.68M -100% 30 Sep 2023 10-Q 09 Nov 2023
Q2 2023 $3.27M +$608K +22.8% 30 Jun 2023 10-Q 11 Aug 2023
Q1 2023 $2.64M -$166K -5.91% 31 Mar 2023 10-Q 11 May 2023
Q4 2022 $517K -$3.06M -85.5% 31 Dec 2022 10-K/A 18 Nov 2024
Q3 2022 $2.68M +$2.68M 30 Sep 2022 10-Q 03 Nov 2022
Q2 2022 $2.66M +$2.66M 30 Jun 2022 10-Q 04 Aug 2022
Q1 2022 $2.81M +$2.81M 31 Mar 2022 10-Q 05 May 2022
Q4 2021 $3.58M +$3.58M 31 Dec 2021 10-K 02 Mar 2023
Q3 2021 $0 30 Sep 2021 10-Q 03 Nov 2022
Q2 2021 $0 30 Jun 2021 10-Q 04 Aug 2022
Q1 2021 $0 31 Mar 2021 10-Q 05 May 2022
Q4 2020 $0 31 Dec 2020 10-K 02 Mar 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.